Biotechnology, Pharmaceutical and Life Science Reports and Courses

Main Pages

Best Selling Products

BioNewsCast Press Release Distribution Service

3rd Annual Stability Testing Conference

Next-Gen Sequencing Trends 2009

Competitor Analysis: c-MET/HGF Inhibitors

The Japanese Pharmaceutical Market 2008-2023

New Products

Japanese Pharmaceutical Market 2009-2024

3rd Annual Lyophilisation Conference

The Global Bioinformatics Market: Market size, forecasts and company profiles

Pharmaceutical Mergers and Acquisitions (PH133)

Pharmaceutical Speaker Programs (PH134) Measuring ROI and Communicating Value

Strategic Clinical Sourcing (PH125)) Managing Costs and CROs

The Global Analgesics Market 2009-2024

Competitor Analysis: Coagulation Factors

Competitor Analysis: PDGF-R Agonists and Antagonists

World Market for Addiction Disorders, 2009-2016

BioPortfolio | Business Insights | Innovations and Pipelines for Respiratory Disorders: Niche markets, new products and future developments

Innovations and Pipelines for Respiratory Disorders: Niche markets, new products and future developments

The market for respiratory disorder treatments is continuing to experience rapid expansion as healthcare payors increasingly acknowledge the high treatment costs associated with chronic indications. A shift in developmental focus has become the driving force for market transformation, with research efforts now targeting the causative disease pathway in an effort to prevent symptom presentation and pathological decline. In the short term, a number of impending product launches will satisfy unmet demand within high-value market niches by addressing issues of patient compliance and targeting patients at the more severe end of the disease spectrum. "Innovations and Pipelines for Respiratory Disorders" is a new report published by Business Insights that examines the future of the respiratory disorders market and explores the dynamics and drivers for current and emerging treatments. This report assesses leading mechanisms of action in drug development pipelines based upon clinical/preclinical results, potential market positioning and sales success in addition to identifying associated investment opportunities. The major trends and issues affecting new product development are highlighted and the future potential of leading innovations is evaluated. This report also identifies major areas of unmet market need and provides a detailed assessment of the currently marketed portfolios and developmental products of key companies within the sector. Explore the latest trends and innovations in respiratory treatments, assess the performances of currently marketed medications and evaluate the potential of leading pipeline candidates with this report.

Published: August 2008 - Global. Format PDF
Table of Contents

BioPortfolio uses RBS Worldpay Secure Server for credit card transactions